Symbols / IGMS
IGMS Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-11-06 15:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- IGMS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of IGM Biosciences, Inc. is Fair to - EIN News ue, 24 Feb 2026 18
- IGM Biosciences Enters into Agreement to Be Acquired by - GlobeNewswire ue, 01 Jul 2025 07
- How IGM’s Leadership Succession Plan At IGM Financial (TSX:IGM) Has Changed Its Investment Story - simplywall.st Mon, 23 Feb 2026 04
- Pharma News: What is the long term forecast for IGMS stock - Weekly Profit Analysis & Breakout Confirmation Trade Signals - baoquankhu1.vn Mon, 23 Feb 2026 03
- IGM Biosciences Merges with Concentra Biosciences - TipRanks hu, 14 Aug 2025 07
- Concentra to acquire IGM Biosciences for $1.247 per share plus CVR - Investing.com ue, 01 Jul 2025 07
- IGM Biosciences Shares Drop 68% as Company Halts Key Programs and Cuts Workforce - Yahoo Finance Fri, 10 Jan 2025 08
- IGM Biosciences Stock: Bad News With No Turnaround In Sight - Seeking Alpha Fri, 10 Jan 2025 08
- IGM Bio (IGMS) Stock Rallies 142% in 3 Months: Here's Why - Nasdaq ue, 16 Jan 2024 08
- IGM’s autoimmune pivot backfires as top drug disappoints in testing - BioPharma Dive hu, 09 Jan 2025 08
- Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover - Investor's Business Daily ue, 01 Oct 2024 07
- IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out, sending stock down 69% - MarketWatch hu, 09 Jan 2025 08
- IGM Biosciences CEO Mary Beth Harler sells $9,014 in stock - Investing.com ue, 18 Mar 2025 07
- IGM Biosciences to be acquired by Concentra - The Pharma Letter Wed, 02 Jul 2025 07
- IGM Biosciences Stock Drops Sharply on ‘Pipeline Transformation’ to Autoimmune Diseases - Barron's ue, 01 Oct 2024 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for IGMS
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|